Brean Murray Carret & Co. Maintains a 'Buy' Pharmasset (VRUS); Abbott (ABT) Hep C Pipeline Not More Risky Than Any Other Four Drug Combo
Go back to Brean Murray Carret & Co. Maintains a 'Buy' Pharmasset (VRUS); Abbott (ABT) Hep C Pipeline Not More Risky Than Any Other Four Drug Combo| Abbott Laboratories (NYSE: ABT) | Delayed: 114.14 -0.29 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.43 | 52 Week High | $46.38 | |||
| Open | $114.00 | 52 Week Low | $36.00 | |||
| Day High | $115.23 | P/E | 76.09 | |||
| Day Low | $113.99 | EPS | $1.50 | |||
| Volume | 5,785,036 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
